Retraction notice to "Efficacy of Sunitinib and Radiotherapy in Genetically Engineered Mouse Model of Soft-Tissue Sarcoma" Int J Radiat Oncol Biol Phys, 2009; 74(4), pp 1207-1216
Int J Radiat Oncol Biol Phys. 2025 Jun 1;122(2):524.
doi: 10.1016/j.ijrobp.2025.03.057.
1 Department of Surgery, Division of Surgical Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
2 Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
3 Harvard-Partners Center for Genetics and Genomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
4 Vascular Biology Program and Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, MA.
5 Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
6 Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
7 Center for Cancer Research, Department of Biology, and Howard Hughes Medical Institute, Massachusetts Institute of Technology, Boston, MA.
8 Departments of Radiation Oncology and Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC.